Despite preparative work by the bio/pharma industry, any Brexit scenario will result in regulatory implications and increased costs.
Vincenzo Salvatore
Advertisement
Vincenzo Salvatore is team leader Healthcare and Life Sciences Focus Team, BonelliErede.
Articles by Vincenzo Salvatore
Advertisement
Latest Updated Articles
The Cost of BrexitPublished: November 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
